Brain 5-HT2A receptors in MPTP monkeys and levodopa-induced dyskinesias (Q83892600)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21501255%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Brain 5-HT(2A) receptors in MPTP monkeys and levodopa-induced dyskinesias (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21501255%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Brain 5-HT2A receptors in MPTP monkeys and levodopa-induced dyskinesias (English)

1 reference

Crossref

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Thérèse Di Paolo-Chênevert

30 November 2024

author

series ordinal

object named as

Thérèse Di Paolo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21501255

30 November 2024

Golnasim Riahi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21501255%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Marc Morissette

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21501255%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Martin Parent

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21501255%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

language of work or name

English

0 references

publication date

19 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21501255%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

28 January 2020

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1460-9568.2011.07675.x

1 reference

Crossref

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1460-9568.2011.07675.x/fullpdf

30 November 2024

1 reference

Crossref

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

European Journal of Neuroscience

30 November 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21501255%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21501255%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21501255%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

1823-1831

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21501255%20AND%20SRC:MED&resulttype=core&format=json

Chronic treatment with small doses of cabergoline prevents dopa-induced dyskinesias in parkinsonian monkeys

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Presymptomatic compensation in Parkinson's disease is not dopamine-mediated

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Activation, internalization, and recycling of the serotonin 2A receptor by dopamine.

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Combined intrastriatal dopamine d1 and serotonin 5-ht2 receptor stimulation reveals a mechanism for hyperlocomotion in 6-hydroxydopamine-lesioned rats

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958.

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

A novel class of 5-HT2A receptor antagonists: aryl aminoguanidines

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Local injections of the 5-hydroxytryptamine antagonist mianserin into substantia nigra pars reticulata block tremulous jaw movements in rats: studies with a putative model of Parkinsonian tremor

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Antiparkinsonian and antidyskinetic activity of drugs targeting central glutamatergic mechanisms

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Post-synaptic 5-HT1A and 5-HT2A receptors are increased in Parkinson's disease neocortex

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Gonadal hormones modulate 5-hydroxytryptamine2A receptors: emphasis on the rat frontal cortex

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Serotonergic Agents That Activate 5HT2A Receptors Prevent NMDA Antagonist Neurotoxicity

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Serotonin and Parkinson's disease: On movement, mood, and madness

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Synergistic interaction between serotonin-2 receptor and dopamine D1 receptor stimulation on striatal preprotachykinin mRNA expression in the 6-hydroxydopamine lesioned rat.

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

The prefrontal cortex and the integration of sensory, limbic and autonomic information

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Effect of a selective glutamate antagonist on L-dopa-induced dyskinesias in drug-naive parkinsonian monkeys

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Ketanserin analogues: the effect of structural modification on 5-HT2 serotonin receptor binding

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Molecular mechanisms of L-DOPA-induced dyskinesia

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Dopamine receptor agonists regulate levels of the serotonin 5-HT2A receptor and its mRNA in a subpopulation of rat striatal neurons

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Aripiprazole in L-dopa-induced dyskinesias: a one-year open-label pilot study.

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalin

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Widespread increases of cortical serotonin type 2A receptor availability after hormone therapy in euthymic postmenopausal women

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

High-frequency stimulation of the subthalamic nucleus and L-3,4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson's disease.

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Ca2+ mobilizing agents mimic serotonin 5-HT2A facilitation of N-methyl-D-aspartate depolarization

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Quetiapine attenuates levodopa-induced motor complications in rodent and primate parkinsonian models

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Serotonin receptors in the human brain--IV. Autoradiographic mapping of serotonin-2 receptors

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Extensive loss of brain dopamine and serotonin induced by chronic administration of MPTP in the marmoset

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey.

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Activation of 5-HT2 receptors facilitates depolarization of neocortical neurons by N-methyl-D-aspartate

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

ACP-103, a 5-HT2A receptor inverse agonist

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Subcellular distribution of 5-hydroxytryptamine2A and N-methyl-D-aspartate receptors within single neurons in rat motor and limbic striatum

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Estradiol modulation of cortical, striatal and raphe nucleus 5-HT1A and 5-HT2A receptors of female hemiparkinsonian monkeys after long-term ovariectomy

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

30 November 2024

Brain dopamine receptors

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Effect of pulsatile administration of levodopa on dyskinesia induction in drug‐naïve MPTP‐treated common marmosets: Effect of dose, frequency of administration, and brain exposure

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Serotonin 2A receptor antagonist treatment reduces dopamine D1 receptor-mediated rotational behavior but not L-DOPA-induced abnormal involuntary movements in the unilateral dopamine-depleted rat.

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

The firing activity of pyramidal neurons in medial prefrontal cortex and their response to 5-hydroxytryptamine-1A receptor stimulation in a rat model of Parkinson's disease.

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

Changes on 5-HT2 receptor mRNAs in striatum and subthalamic nucleus in Parkinson's disease model

30 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1460-9568.2011.07675.X

30 November 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21501255%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21501255%20AND%20SRC:MED&resulttype=core&format=json